ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+7.09%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$354M
AUM Growth
+$354M
(+14%)
Cap. Flow
+$25.3M
Cap. Flow
% of AUM
7.15%
Top 10 Holdings %
Top 10 Hldgs %
34.16%
Holding
110
New
22
Increased
38
Reduced
31
Closed
18
Top Buys
| 1 |
McKesson
MCK
|
$10M |
| 2 |
Thermo Fisher Scientific
TMO
|
$9.41M |
| 3 |
iRhythm Technologies
IRTC
|
$7.03M |
| 4 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$6.97M |
| 5 |
Dentsply Sirona
XRAY
|
$6.32M |
Top Sells
| 1 |
CTLT
CATALENT, INC.
CTLT
|
$8.25M |
| 2 |
VWR
VWR Corporation
VWR
|
$7.23M |
| 3 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
$5.2M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
$4.63M |
| 5 |
Hologic
HOLX
|
$4.59M |
Sector Composition
| 1 | Healthcare | 88.14% |
| 2 | Financials | 2.42% |
| 3 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
VanEck Biotech ETF
BBH
$350M
| $5.78M | 1.63% | 45,999 +27,549 | +149% | +$3.46M |
|
27
Viatris
VTRS
$12.3B
| $5.26M | 1.49% | 135,600 +44,500 | +49% | +$1.73M |
|
28
Cencora
COR
$56.5B
| $4.36M | 1.23% | 46,140 -23,600 | -34% | -$2.23M |
|
|
NVRO
29
DELISTED
NEVRO CORP.
NVRO
| $4.26M | 1.21% | 57,261 +39,241 | +218% | +$2.92M |
|
30
CVS Health
CVS
$92.8B
| $3.89M | 1.1% | 48,300 -9,800 | -17% | -$788K |
|
|
WBA
31
DELISTED
Walgreens Boots Alliance
WBA
| $3.75M | 1.06% | 47,864 -28,000 | -37% | -$2.19M |
|
32
Boston Scientific
BSX
$156B
| $3.54M | 1% | 127,698 -98,500 | -44% | -$2.73M |
|
33
Medtronic
MDT
$119B
| $3.52M | 0.99% | 39,600 +14,700 | +59% | +$1.3M |
|
|
KTWO
34
DELISTED
K2M Group Holdings, Inc
KTWO
| $3.4M | 0.96% | 139,400 +21,200 | +18% | +$516K |
|
|
CLVS
35
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.96M | 0.84% | 31,650 -200 | -0.6% | -$18.7K |
|
36
Charles River Laboratories
CRL
$8.04B
| $2.86M | 0.81% | 28,248 +4,460 | +19% | +$451K |
|
|
AERI
37
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $2.79M | 0.79% | 53,030 +19,700 | +59% | +$1.04M |
|
|
NXTM
38
DELISTED
NxStage Medical Inc.
NXTM
| $2.72M | 0.77% | +108,300 | New | +$2.72M |
|
39
Edwards Lifesciences
EW
$47.8B
| $2.64M | 0.75% | 22,316 +1,000 | +5% | +$118K |
|
40
Incyte
INCY
$16.5B
| $2.54M | 0.72% | 20,200 +7,000 | +53% | +$881K |
|
|
DERM
41
DELISTED
Dermira, Inc.
DERM
| $2.23M | 0.63% | 76,488 +45,300 | +145% | +$1.32M |
|
42
Centene
CNC
$14.3B
| $2.16M | 0.61% | 27,076 -15,700 | -37% | -$1.25M |
|
|
NUVA
43
DELISTED
NuVasive, Inc.
NUVA
| $2.14M | 0.6% | +27,800 | New | +$2.14M |
|
44
Teva Pharmaceuticals
TEVA
$21.1B
| $2.09M | 0.59% | 62,833 +10,100 | +19% | +$335K |
|
|
TVTY
45
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $1.9M | 0.54% | 47,700 +15,800 | +50% | +$630K |
|
46
GSK
GSK
$79.9B
| $1.88M | 0.53% | 43,500 -88,200 | -67% | -$3.8M |
|
47
Brookdale Senior Living
BKD
$1.83B
| $1.86M | 0.53% | +126,500 | New | +$1.86M |
|
|
MNK
48
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $1.77M | 0.5% | 39,575 -30,553 | -44% | -$1.37M |
|
49
Halozyme
HALO
$8.56B
| $1.76M | 0.5% | 136,900 -39,200 | -22% | -$503K |
|
|
ARA
50
DELISTED
American Renal Associates Holdings, Inc
ARA
| $1.75M | 0.5% | 94,408 +48,430 | +105% | +$898K |
|